Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Mol Clin Oncol. 2019 Dec;11(6):557-562. doi: 10.3892/mco.2019.1930. Epub 2019 Oct 3.

2.

Perturbed development of cranial neural crest cells in association with reduced sonic hedgehog signaling underlies the pathogenesis of retinoic-acid-induced cleft palate.

Wang Q, Kurosaka H, Kikuchi M, Nakaya A, Trainor PA, Yamashiro T.

Dis Model Mech. 2019 Oct 4;12(10). pii: dmm040279. doi: 10.1242/dmm.040279.

3.

[Apolipoprotein E4, a Genetic Risk Factor for Alzheimer's Disease].

Kikuchi M, Nakaya A.

Brain Nerve. 2019 Oct;71(10):1053-1060. doi: 10.11477/mf.1416201404. Review. Japanese.

PMID:
31588049
4.

A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms.

Nakanishi T, Nakaya A, Nishio Y, Fujita S, Satake A, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Kadosaka Y, Ishii K, Ito T, Tsuta K, Nomura S.

Hematol Rep. 2019 Sep 18;11(3):7971. doi: 10.4081/hr.2019.7971. eCollection 2019 Sep 18.

5.

Basophil-expressing genes related with the efficacy of sublingual immunotherapy.

Gotoh M, Kaminuma O, Nakaya A, Saeki M, Nishimura T, Kitamura N, Hiroi T, Kimihiro Okubo A.

J Nippon Med Sch. 2019 Sep 30. doi: 10.1272/jnms.JNMS.2020_87-104. [Epub ahead of print]

6.

Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.

Kikuchi M, Hara N, Hasegawa M, Miyashita A, Kuwano R, Ikeuchi T, Nakaya A.

BMC Med Genomics. 2019 Sep 9;12(1):128. doi: 10.1186/s12920-019-0574-8.

7.

[Mechanisms of allergen immunotherapy elucidated through integrated comparative analysis].

Kaminuma O, Gotoh M, Okubo K, Nakaya A, Hiroi T.

Nihon Yakurigaku Zasshi. 2019;154(1):23-27. doi: 10.1254/fpj.154.23. Review. Japanese.

PMID:
31308346
8.

[A case of recurrent cerebral infarction during treatment with oral tyrosine kinase inhibitors for chronic myelogenous leukemia].

Nakaya A, Ebitani M, Monzen T, Nagno T, Saito F, Yaoita Y.

Rinsho Shinkeigaku. 2019 Jul 31;59(7):418-424. doi: 10.5692/clinicalneurol.cn-001222. Epub 2019 Jun 27. Japanese.

PMID:
31243247
9.

Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 May 25;12:100174. doi: 10.1016/j.lrr.2019.100174. eCollection 2019. No abstract available.

10.

Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma.

Azuma Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 May 25;12:100173. doi: 10.1016/j.lrr.2019.100173. eCollection 2019.

11.

Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.

Ito T, Hashimoto Y, Tanaka Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Konishi A, Hotta M, Yoshimura H, Ishii K, Hashimoto A, Kondo T, Omura H, Shinzato I, Tanaka T, Nomura S.

Eur J Haematol. 2019 Aug;103(2):116-123. doi: 10.1111/ejh.13265. Epub 2019 Jun 17.

PMID:
31107982
12.

Evaluation of eltrombopag in patients with aplastic anemia in real-world experience.

Konishi A, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 Mar 5;11:11-13. doi: 10.1016/j.lrr.2019.03.002. eCollection 2019.

13.

Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia.

Ishii K, Nakaya A, Fujita S, Satake A, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ito T, Nomura S.

Leuk Res Rep. 2019 Mar 5;11:8-10. doi: 10.1016/j.lrr.2019.03.001. eCollection 2019.

14.

Response to "Genetics of Periodontitis without Bias".

Masumoto R, Kitagaki J, Fujihara C, Matsumoto M, Miyauchi S, Asano Y, Imai A, Kobayashi K, Nakaya A, Yamashita M, Yamada S, Kitamura M, Murakami S.

J Periodontal Res. 2019 Oct;54(5):455-456. doi: 10.1111/jre.12652. Epub 2019 Mar 21. No abstract available.

PMID:
30900245
15.

Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.

Niki M, Nakaya A, Kurata T, Nakahama K, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S.

Mol Clin Oncol. 2019 Feb;10(2):267-269. doi: 10.3892/mco.2018.1777. Epub 2018 Nov 27.

16.

Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background.

Imai-Okazaki A, Kishita Y, Kohda M, Mizuno Y, Fushimi T, Matsunaga A, Yatsuka Y, Hirata T, Harashima H, Takeda A, Nakaya A, Sakata Y, Kogaki S, Ohtake A, Murayama K, Okazaki Y.

Int J Cardiol. 2019 Mar 15;279:115-121. doi: 10.1016/j.ijcard.2019.01.017. Epub 2019 Jan 5.

PMID:
30642647
17.

Serum Cytokine Interactions Are Implicated in the Mechanism of Action of Sublingual Immunotherapy for Japanese Cedar Pollinosis.

Shimada K, Gotoh M, Okubo K, Hiroi T, Kaminuma O, Nakaya A.

J Nippon Med Sch. 2018;85(5):250-258. doi: 10.1272/jnms.JNMS.2018_85-40.

18.

Identification of genetic risk factors of aggressive periodontitis using genomewide association studies in association with those of chronic periodontitis.

Masumoto R, Kitagaki J, Fujihara C, Matsumoto M, Miyauchi S, Asano Y, Imai A, Kobayashi K, Nakaya A, Yamashita M, Yamada S, Kitamura M, Murakami S.

J Periodontal Res. 2019 Jun;54(3):199-206. doi: 10.1111/jre.12620. Epub 2018 Oct 10. Review.

PMID:
30303256
19.

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Hematol Rep. 2018 Sep 5;10(3):7474. doi: 10.4081/hr.2018.7474. eCollection 2018 Sep 5.

20.

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer.

Niki M, Nakaya A, Kurata T, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S.

Oncotarget. 2018 Aug 17;9(64):32298-32304. doi: 10.18632/oncotarget.25949. eCollection 2018 Aug 17.

21.

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.

Ito T, Konishi A, Tsubokura Y, Azuma Y, Hotta M, Yoshimura H, Nakanishi T, Fujita S, Nakaya A, Satake A, Ishii K, Nomura S.

Front Nutr. 2018 Aug 21;5:72. doi: 10.3389/fnut.2018.00072. eCollection 2018.

22.

[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].

Ishii K, Azuma Y, Konishi A, Tsubokura Y, Yoshimura H, Hotta M, Nakanishi T, Nakaya A, Fujita S, Satake A, Miyaji M, Ito T, Nomura S.

Rinsho Ketsueki. 2018;59(8):1002-1006. doi: 10.11406/rinketsu.59.1002. Japanese.

PMID:
30185698
23.

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia.

Kikuchi M, Miura K, Morita K, Yamamori H, Fujimoto M, Ikeda M, Yasuda Y, Nakaya A, Hashimoto R.

Sci Rep. 2018 Aug 17;8(1):12347. doi: 10.1038/s41598-018-30646-9.

24.

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia.

Hotta M, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Yoshimura H, Ito T, Ishii K, Nomura S.

Hematol Rep. 2018 May 16;10(2):7527. doi: 10.4081/hr.2018.7527. eCollection 2018 May 14.

25.

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry.

Nakaya A, Yagi H, Kaneko H, Kosugi S, Kida T, Adachi Y, Shibayama H, Kohara T, Kamitsuji Y, Fuchida SI, Uoshima N, Kawata E, Uchiyama H, Shimura Y, Takahashi T, Urase F, Ohta K, Hamada T, Miyamoto K, Kobayashi M, Shindo M, Tanaka H, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaoari-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.

Leuk Res Rep. 2018 Jul 4;10:7-10. doi: 10.1016/j.lrr.2018.07.001. eCollection 2018.

26.

Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide.

Ito T, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Hotta M, Yoshimura H, Ishii K, Nomura S.

Leuk Res Rep. 2018 Jul 7;10:4-6. doi: 10.1016/j.lrr.2018.06.005. eCollection 2018.

27.

Human T-cell Leukemia Virus Type I Associated with an Increased Risk of Primary Malignant Neoplasm.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Mediterr J Hematol Infect Dis. 2018 Apr 20;10(1):e2018024. doi: 10.4084/MJHID.2018.024. eCollection 2018. No abstract available.

28.

Involvement of taste receptors in the effectiveness of sublingual immunotherapy.

Gotoh M, Kaminuma O, Nakaya A, Katayama K, Watanabe N, Saeki M, Nishimura T, Kitamura N, Okubo K, Hiroi T.

Allergol Int. 2018 Jul;67(3):421-424. doi: 10.1016/j.alit.2018.02.003. Epub 2018 Mar 6. No abstract available.

29.

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab.

Nakaya A, Kurata T, Yoshioka H, Takeyasu Y, Niki M, Kibata K, Satsutani N, Ogata M, Miyara T, Nomura S.

Int J Clin Oncol. 2018 Aug;23(4):634-640. doi: 10.1007/s10147-018-1250-2. Epub 2018 Feb 13.

30.

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

Nomura S, Ito T, Yoshimura H, Hotta M, Nakanishi T, Fujita S, Nakaya A, Satake A, Ishii K.

J Blood Med. 2018 Jan 19;9:1-7. doi: 10.2147/JBM.S147743. eCollection 2018.

31.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
32.

Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection.

Nakaya A, Azuma Y, Fujita S, Satake A, Nakanishi T, Tsubokura Y, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Hematol Rep. 2017 Dec 22;9(4):7415. doi: 10.4081/hr.2017.7415. eCollection 2017 Dec 22. No abstract available.

33.

Barth Syndrome: Different Approaches to Diagnosis.

Imai-Okazaki A, Kishita Y, Kohda M, Yatsuka Y, Hirata T, Mizuno Y, Harashima H, Hirono K, Ichida F, Noguchi A, Yoshida M, Tokorodani C, Nishiuchi R, Takeda A, Nakaya A, Sakata Y, Murayama K, Ohtake A, Okazaki Y.

J Pediatr. 2018 Feb;193:256-260. doi: 10.1016/j.jpeds.2017.09.075. Epub 2017 Dec 15.

PMID:
29249525
34.

Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case report.

Takeyasu Y, Satake A, Azuma Y, Tsubokura Y, Yoshimura H, Hotta M, Nakanishi T, Fujita S, Nakaya A, Ito T, Nomura S.

Clin Case Rep. 2017 Nov 2;5(12):2047-2050. doi: 10.1002/ccr3.1253. eCollection 2017 Dec.

35.

Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer.

Nakaya A, Kurata T, Yokoi T, Takeyasu Y, Niki M, Kibata K, Satsutani N, Torii Y, Katashiba Y, Ogata M, Miyara T, Nomura S.

Mol Clin Oncol. 2017 Nov;7(5):803-807. doi: 10.3892/mco.2017.1392. Epub 2017 Aug 25.

36.

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.

Tsukune Y, Sasaki M, Odajima T, Sunami K, Takei T, Moriuchi Y, Iino M, Isoda A, Nakaya A, Muta T, Miyake T, Miyazaki K, Shimizu T, Nakajima K, Igarashi A, Nagafuji K, Kurihara T, Aoyama T, Sugimori H, Komatsu N.

Blood Cancer J. 2017 Nov 23;7(12):631. doi: 10.1038/s41408-017-0002-2. No abstract available.

37.

Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein.

Yamamoto S, Kaimori JY, Yoshimura T, Namba T, Imai A, Kobayashi K, Imamura R, Ichimaru N, Kato K, Nakaya A, Takahara S, Isaka Y.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2010-2017. doi: 10.1093/ndt/gfx083.

PMID:
29156055
38.

Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Case Rep Oncol. 2017 Oct 5;10(3):871-875. doi: 10.1159/000481166. eCollection 2017 Sep-Dec.

39.

Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Oncol Lett. 2017 Sep;14(3):3803-3808. doi: 10.3892/ol.2017.6589. Epub 2017 Jul 15.

40.

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer.

Nakatani Y, Nakaya A, Kurata T, Yokoi T, Takeyasu Y, Niki M, Kibata K, Satsutani N, Ogata M, Miyara T, Nomura S.

Case Rep Oncol. 2017 Aug 4;10(2):683-688. doi: 10.1159/000479148. eCollection 2017 May-Aug.

41.

Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation.

Kurata T, Nakaya A, Yokoi T, Niki M, Kibata K, Takeyasu Y, Torii Y, Katashiba Y, Ogata M, Miyara T, Nomura S.

Genes Cancer. 2017 May;8(5-6):559-565. doi: 10.18632/genesandcancer.145.

42.

[Bioinformatics Analysis of Alzheimer's Disease].

Kikuchi M, Nakaya A.

Brain Nerve. 2017 Jul;69(7):835-842. doi: 10.11477/mf.1416200828. Japanese.

PMID:
28739998
43.

Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Acta Haematol. 2017;138(1):55-60. doi: 10.1159/000477792. Epub 2017 Jul 21.

44.

HDR-del: A tool based on Hamming distance for prioritizing pathogenic chromosomal deletions in exome sequencing.

Imai-Okazaki A, Kohda M, Kobayashi K, Hirata T, Sakata Y, Murayama K, Ohtake A, Okazaki Y, Nakaya A, Ott J.

Hum Mutat. 2017 Dec;38(12):1796-1800. doi: 10.1002/humu.23298. Epub 2017 Sep 21.

PMID:
28722338
45.

Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.

Nomura S, Ishii K, Fujita S, Nakaya A, Satake A, Ito T.

Transpl Immunol. 2017 Aug;43-44:27-32. doi: 10.1016/j.trim.2017.06.004. Epub 2017 Jul 5.

46.

Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.

Gotoh M, Kaminuma O, Nakaya A, Katayama K, Motoi Y, Watanabe N, Saeki M, Nishimura T, Kitamura N, Yamaoka K, Okubo K, Hiroi T.

Int Immunol. 2017 Jun 1;29(6):291-300. doi: 10.1093/intimm/dxx034.

PMID:
28575522
47.

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.

Kinoshita M, Numata S, Tajima A, Yamamori H, Yasuda Y, Fujimoto M, Watanabe S, Umehara H, Shimodera S, Nakazawa T, Kikuchi M, Nakaya A, Hashimoto H, Imoto I, Hashimoto R, Ohmori T.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E632. doi: 10.3390/ijms18030632.

48.

Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Hematol Rep. 2017 Feb 23;9(1):6887. doi: 10.4081/hr.2017.6887. eCollection 2017 Feb 23.

49.

Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.

Nakazawa T, Kikuchi M, Ishikawa M, Yamamori H, Nagayasu K, Matsumoto T, Fujimoto M, Yasuda Y, Fujiwara M, Okada S, Matsumura K, Kasai A, Hayata-Takano A, Shintani N, Numata S, Takuma K, Akamatsu W, Okano H, Nakaya A, Hashimoto H, Hashimoto R.

Schizophr Res. 2017 Mar;181:75-82. doi: 10.1016/j.schres.2016.10.012. Epub 2016 Oct 27.

50.

Sphingomyelin Phosphodiesterase 3 Enhances Cytodifferentiation of Periodontal Ligament Cells.

Miyauchi S, Kitagaki J, Masumoto R, Imai A, Kobayashi K, Nakaya A, Kawai S, Fujihara C, Asano Y, Yamashita M, Yanagita M, Yamada S, Kitamura M, Murakami S.

J Dent Res. 2017 Mar;96(3):339-346. doi: 10.1177/0022034516677938. Epub 2016 Nov 16.

PMID:
28221099

Supplemental Content

Loading ...
Support Center